SFM
TEVA icon

Systematic Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History

Systematic Financial Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-71,000
Closed -$1.09M – 670
2018
Q4 		$1.09M Sell
71,000
-242,868
-77% -$4.98M 0.03% 429
2018
Q3 		$6.76M Buy
313,868
+124,983
+66% +$2.9M 0.16% 203
2018
Q2 		$4.59M Buy
+188,885
New +$3.85M 0.11% 229
2016
Q4 		– Sell
-199,567
Closed -$9.18M – 668
2016
Q3 		$9.18M Sell
199,567
-5,748
-3% -$300K 0.13% 198
2016
Q2 		$10.3M Sell
205,315
-36,670
-15% -$1.95M 0.14% 176
2016
Q1 		$12.9M Sell
241,985
-7,901
-3% -$464K 0.16% 154
2015
Q4 		$16.4M Sell
249,886
-6,012
-2% -$372K 0.18% 111
2015
Q3 		$14.4M Sell
255,898
-193,769
-43% -$12.6M 0.15% 139
2015
Q2 		$26.6M Sell
449,667
-65,990
-13% -$4.07M 0.23% 116
2015
Q1 		$32.1M Sell
515,657
-31,997
-6% -$1.86M 0.25% 110
2014
Q4 		$31.5M Buy
547,654
+40,498
+8% +$2.26M 0.23% 108
2014
Q3 		$27.3M Sell
507,156
-10,449
-2% -$554K 0.2% 123
2014
Q2 		$27.1M Buy
517,605
+15,271
+3% +$781K 0.19% 129
2014
Q1 		$26.5M Buy
502,334
+485,664
+2,913% +$22.4M 0.18% 138
2013
Q4 		$668K Sell
16,670
-3,300
-17% -$130K ﹤0.01% 604
2013
Q3 		$754K Hold
19,970
– – 0.01% 597
2013
Q2 		$782K Buy
+19,970
New +$778K 0.01% 588

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Systematic Financial Management's TEVA Position: Q1 2019 in Review

Systematic Financial Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 71,000 shares — an estimated $1.09M sold.

Systematic Financial Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $32.1M in Q1 2015. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Systematic Financial Management reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Systematic Financial Management sold 71,000 Teva Pharmaceuticals shares in Q1 2019, an estimated $1.09M.
  • Systematic Financial Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Systematic Financial Management's Teva Pharmaceuticals position peaked at $32.1M in Q1 2015.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Systematic Financial Management's 13F filing for Q1 2019, filed 3 May 2019.